文献速递衰弱、肌少症与跌倒老年慢病共病管理

肌少症与人类白细胞抗原复合体的变异关联

Sarcopenia and Variation in the Human Leukocyte Antigen Complex.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2020-01-01

在181,301名60-70岁英国生物银行欧洲裔志愿者中,自身免疫诊断与肌少症强相关(OR 1.83)。排除自身免疫诊断后,特定HLA类型及非编码变异仍与肌少症相关,部分关联在女性中更强。

要点

  • 自身免疫诊断与肌少症强相关(OR 1.83)。
  • 无自身免疫诊断者中,6/100 HLA类型与肌少症相关。
  • 携带两个HLA-DQA1*03:01等位基因者肌少症风险增加19.3%。

核心结论

  • 自身免疫诊断与60-70岁人群肌少症强相关。
  • 无自身免疫诊断的老年人中,特定HLA类型和非编码SNP仍与肌少症相关。

研究设计与样本

  • 数据来自181,301名60-70岁英国生物银行欧洲裔志愿者,测量握力和阻抗。
  • 采用逻辑回归分析HLA类型与肌少症的关联,校正混杂因素和多重检验。

主要发现

  • 任何自身免疫诊断与肌少症相关(OR 1.83,95%CI 1.74-1.92,p=4.0*10-125)。
  • 排除自身免疫诊断后,100种HLA类型(等位基因频率>1%)中6种与肌少症相关。
  • 携带两个HLA-DQA1*03:01等位基因者肌少症风险增加19.3%(OR 1.19,95%CI 1.09-1.29,p=2.84*10-5)。
  • 12种HLA等位基因中携带≥6种者肌少症风险增加23%(OR 1.23,95%CI 1.12-1.35,p=7.28*10-6)。
  • 658个HLA区域非编码变异中4个与肌少症相关,包括rs41268896(OR 1.08,95%CI 1.05-1.11,p=1.06*10-8)和rs29268645(OR 1.07,95%CI 1.04-1.09,p=1.5*10-6)。

临床怎么用

  • 对肌少症患者应关注自身免疫疾病诊断,可能受益于针对性治疗。

局限性

  • 研究仅纳入欧洲裔人群,结果外推需谨慎。
  • HLA与肌少症的关联在女性中更强,提示性别差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aging is characterized by chronic inflammation plus loss of muscle mass and strength, termed sarcopenia. Human leukocyte antigen (HLA) types are drivers of autoimmune disease, although with limited penetrance. We tested whether autoimmune diagnoses are associated with sarcopenia, and whether HLA types and related genetic variants are associated with sarcopenia in autoimmune disease-free older people. METHODS: Data were collected from 181,301 UK Biobank European descent volunteers aged 60-70 with measured hand grip strength and impedance. Logistic regression analysis estimated HLA type and sarcopenia associations, adjusted for confounders and multiple testing. RESULTS: Having any autoimmune diagnosis was associated with sarcopenia (odds ratio [OR] 1.83, 95% confidence interval (CI) 1.74-1.92, p = 4.0*10-125). After excluding autoimmune diagnoses, 6 of 100 HLA types (allele frequency >1%) were associated with sarcopenia (low grip strength and muscle mass). Having two HLA-DQA1*03:01 alleles increased odds of sarcopenia by 19.3% (OR 1.19, CI 1.09-1.29, p = 2.84*10-5), compared to no alleles. Having ≥6 of the 12 HLA alleles increased sarcopenia odds by 23% (OR 1.23, CI 1.12-1.35, p = 7.28*10-6). Of 658 HLA region non-coding genetic variants previously implicated in disease, 4 were associated with sarcopenia, including rs41268896 and rs29268645 (OR 1.08, CI 1.05-1.11, p = 1.06*10-8 and 1.07, CI 1.04-1.09, p = 1.5*10-6, respectively). Some HLA associations with sarcopenia were greater in female participants. CONCLUSION: Autoimmune diagnoses are strongly associated with sarcopenia in 60- to 70-year olds. Variation in specific HLA types and non-coding single nucleotide polymorphisms is also associated with sarcopenia in older carriers free of diagnosed autoimmune diseases. Patients with sarcopenia might benefit from targeted treatment of autoimmune processes.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Jones G, Pilling LC, Kuo CL, et al. Sarcopenia and Variation in the Human Leukocyte Antigen Complex. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30772894. doi:10.1093/gerona/glz042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。